A Post-Neurosurgical Infection due to KPC-Producing Klebsiella pneumoniae Treated with Meropenem-Vaborbactam: A Case Report.
Carbapenem-resistant enterobacterales
Central nervous system
Klebsiella pneumoniae carbapenemase
Meropenem-vaborbactam
Post-neurosurgical
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
26
04
2022
revised:
26
07
2022
accepted:
28
07
2022
pubmed:
7
8
2022
medline:
9
9
2022
entrez:
6
8
2022
Statut:
ppublish
Résumé
This case report describes a patient with post-neurosurgical infection and bacteremia caused by Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae. There is limited evidence to guide antibiotic treatment decisions for such infections. The patient was treated with meropenem-vaborbactam (MEV). MEV monotherapy was associated with bacteremia clearance.
Identifiants
pubmed: 35932967
pii: S1201-9712(22)00469-6
doi: 10.1016/j.ijid.2022.07.073
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
Boronic Acids
0
Drug Combinations
0
vaborbactam
1C75676F8V
beta-Lactamases
EC 3.5.2.6
Meropenem
FV9J3JU8B1
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1041-1043Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest MF is an employee at Melinta Therapeutics. SS served on an advisory board for Shionogi Inc. SC, JLT, and NM have no conflicts of interest to declare.